Third-Party Payors Say GSK Skews Avandia Claims
Third-party payors in a class action alleging GlaxoSmithKline LLC misrepresented the safety of its Avandia diabetes drugs told a Pennsylvania federal judge on Thursday that the pharmaceutical company is distorting what...To view the full article, register now.
Already a subscriber? Click here to view full article